Screening olfaction under dupilumab in chronic rhinosinusitis with nasal polyps.
T MautheC M MeerweinF S RyserC Brà HlmannA YalamanogluU C SteinerM B Soyka
Published in: Rhinology (2024)
Dupilumab demonstrated efficacy in restoring olfaction in CRSwNP patients. Reaching normosmia in over 80% ofpatients after six months of treatment underscores the drug's effectiveness in managing this challenging symptom.